Deadline Extended for Employer Participation in Drug Benefit Survey
* Reuters is not responsible for the content in this press release.
SCOTTSDALE, AZ, Apr 22 (MARKET WIRE) --
The Pharmacy Benefit Management Institute (PBMI) has extended the
deadline for employer participation in its annual drug benefit design
survey to May 14. The extension gives all sponsors of drug benefit
programs, including employers, union groups, and associations, an
additional two weeks to participate in the online survey.
PBMI's annual Prescription Drug Benefit Cost and Plan Design Survey
documents decisions organizations are making about their drug benefit
plans to control costs and improve clinical outcomes. In addition to cost
sharing and pharmacy reimbursement trends, the study provides insights on
dispensing channels (retail, mail, specialty), per member per month
utilization metrics, and clinical management tools including academic
detailing, face-to-face consults, and step therapy. The 2010 survey has
been expanded to learn more about how organizations are addressing
specialty pharmacy and personalized medicine.
"Widespread participation in our survey enables PBMI to provide valued
benefits benchmarking resources to all of the professionals involved in
designing and managing drug benefit programs," says Dana H. Felthouse,
MBA, president of PBMI. "We offer incentives for participation and now
have extended the time frame to allow more plan sponsors to complete the
survey."
Plan sponsors (employers, unions and associations) who have not received
a survey invitation should contact PBMI at 480-730-9814 or info@pbmi.com.
PBMI gratefully acknowledges the support of Takeda Pharmaceuticals North
America (TPNA), Inc. for the provision of a grant to cover costs incurred
in the production of print and online versions of the report. TPNA has no
access to the individual responses or raw data gathered, nor do any other
third parties. This protects the confidentiality of the survey
respondents and ensures the independence and objectivity of this report.
The Pharmacy Benefit Management Institute provides research and education
to help health care benefit executives work effectively with pharmacy
benefit managers to improve the design and management of drug benefit
programs. Learn more at www.pbmi.com. To view this release and other PBMI
news, visit www.pbmi.com/news-releases.asp.
Contact:
Maggie Bruce (480) 730-0814
Cell Phone: (602) 318-5003
Email: mbruce@pbmi.com
Copyright 2010, Market Wire, All rights reserved.
-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters